Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cluster Sampling Method01:20

Cluster Sampling Method

14.2K
Appropriate sampling methods ensure that samples are drawn without bias and accurately represent the population. Because measuring the entire population in a study is not practical, researchers use samples to represent the population of interest.
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
14.2K
Vesicular Tubular Clusters01:45

Vesicular Tubular Clusters

3.1K
After budding out from the ER membrane, some COPII vesicles lose their coat and fuse with one another to form larger vesicles and interconnected tubules called vesicular tubular clusters or VTCs. These clusters constitute a compartment at the ER-Golgi interface known as ERGIC (Endoplasmic Reticulum Golgi Intermediate Compartment). The ERGIC is a mobile membrane-bound cargo transport system that sorts proteins secreted from ER and delivers them to the Golgi.
With the help of motor proteins such...
3.1K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

11.6K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.6K
Cis-regulatory Sequences02:02

Cis-regulatory Sequences

4.1K
4.1K
Sanger Sequencing01:57

Sanger Sequencing

773.8K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
773.8K
Identifying Statistically Significant Differences: The F-Test01:14

Identifying Statistically Significant Differences: The F-Test

3.3K
The F-test is used to compare two sample variances to each other or compare the sample variance to the population variance. It is used to decide whether an indeterminate error can explain the difference in their values. The underlying assumptions that allow the use of the F-test include the data set or sets are normally distributed, and the data sets are independent of each other. The test statistic F is calculated by dividing one variance by another. In other words, the square of one standard...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemically induced skin tumors arise from long-lived stem cells of the upper hair follicle.

Science (New York, N.Y.)·2026
Same author

Tumour promotion through the lens of evolution.

Nature·2026
Same author

Proteasome dysfunction underlies HERC2-linked neurodevelopmental disorder with Angelman-like clinical features.

Cell death discovery·2026
Same author

Evaluation of BoostDM, a somatic variant prediction tool, for the interpretation of germline variants in hereditary cancer genes.

European journal of human genetics : EJHG·2026
Same author

Targeting RhoA nuclear mechanoactivity rejuvenates aged hematopoietic stem cells.

Nature aging·2025
Same author

Sex and smoking bias in the selection of somatic mutations in human bladder.

Nature·2025
Same journal

conMItion: an R package adjusting confounding factors for associations in multi-omics.

Bioinformatics (Oxford, England)·2026
Same journal

SpaMFG: a Spatial Multi-omics Integration Method based on Feature Grouping.

Bioinformatics (Oxford, England)·2026
Same journal

CSCN: Inference of Cell-Specific Causal Networks Using Single-Cell RNA-Seq Data.

Bioinformatics (Oxford, England)·2026
Same journal

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same journal

Enhancing Cross-Context Generalization in Drug Perturbation Prediction with a Multimodal Conditional Diffusion Framework.

Bioinformatics (Oxford, England)·2026
Same journal

Primer Design through Submodular Function Estimation.

Bioinformatics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jan 23, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.9K

OncodriveCLUSTL: a sequence-based clustering method to identify cancer drivers.

Claudia Arnedo-Pac1, Loris Mularoni1, Ferran Muiños1

  • 1Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.

Bioinformatics (Oxford, England)
|June 23, 2019
PubMed
Summary
This summary is machine-generated.

A new algorithm, OncodriveCLUSTL, identifies cancer driver genes by detecting mutation clustering. This computational method improves upon existing tools and aids in oncogenomics research.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

364

Related Experiment Videos

Last Updated: Jan 23, 2026

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres
06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.9K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.6K
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
05:17

Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing

Published on: October 10, 2025

364

Area of Science:

  • Oncogenomics
  • Computational Biology
  • Cancer Genomics

Background:

  • Identifying genomic alterations driving tumorigenesis is crucial in cancer research.
  • Computational methods detecting positive selection signals in tumor mutations aid in finding cancer genes.
  • Abnormal mutation clustering is a key signal complementary to other methods for driver gene detection.

Purpose of the Study:

  • To develop a novel sequence-based clustering algorithm, OncodriveCLUSTL.
  • To detect significant mutation clustering signals across genomic regions for identifying cancer drivers.

Main Methods:

  • Developed OncodriveCLUSTL, a sequence-based clustering algorithm.
  • Utilized a local background model simulating mutations based on trinucleotide or pentanucleotide contexts.
  • Applied the algorithm to cohorts of tumor whole-exomes.

Main Results:

  • OncodriveCLUSTL successfully identifies known mutation clusters and bona-fide cancer drivers.
  • The algorithm outperforms the existing OncodriveCLUST method.
  • Results demonstrate complementarity with other positive selection detection methods.
  • OncodriveCLUSTL is applicable to non-coding elements and non-human mutation data.

Conclusions:

  • OncodriveCLUSTL is an effective tool for detecting cancer driver genes through mutation clustering.
  • The algorithm offers improved performance and broader applicability in cancer genomics.
  • This method enhances the search for genomic alterations driving tumorigenesis.